TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ANIP

ANI Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

74.00$ -0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

ANI Pharmaceuticals Inc (ANIP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,494 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANIP
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
319 323 357 359 370 412 418 424 439 431 434 447 457 457 482 465 463 461 464 480 470 772 745 751 739 760 765 859 890 904 915 921 1,287 1,284 1,292 1,343 1,408 1,440 1,422 1,494
95 103 107 113 126 132 143 152 157 153 152 169 182 188 159 157 166 170 183 192 191 322 301 322 309 344 365 459 497 520 541 555 521 528 536 603 698 753 747 825
16 27 11 8.4 18 31 52 55 44 43 38 41 60 62 20 28 18 7.9 25 24 15 100 77 63 56 48 68 162 193 221 229 240 145 145 150 218 263 286 311 360
16 27 11 8.4 18 31 52 55 44 43 38 41 60 62 20 28 18 7.9 25 24 15 100 77 63 56 48 68 162 193 221 238 247 153 151 155 224 263 286 311 376
47 46 47 56 62 59 55 56 68 65 67 76 71 72 82 73 84 96 92 93 107 129 132 150 140 165 175 173 179 162 172 166 196 222 220 226 253 281 255 274
28 26 46 42 38 38 34 38 40 41 42 45 46 48 53 53 59 61 60 68 62 82 83 93 96 105 104 104 107 111 114 125 148 137 137 138 146 143 143 143
9.7 11 13 15 17 20 22 23 37 38 38 39 40 41 40 40 40 41 41 40 40 53 53 44 43 43 43 44 – – – – – – – – – – – –
1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8 4.2 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.6 28 28 28 28 28 28 28 28 28 28 28 60 60 61 61 62 62 62 62
189 176 203 197 190 230 222 217 210 202 205 197 188 180 216 206 199 189 179 180 170 294 282 270 264 252 239 230 220 209 196 183 570 542 538 520 500 480 467 450
151 153 185 183 188 237 238 239 247 233 235 239 244 244 281 274 267 265 260 288 279 413 399 414 402 422 426 425 435 472 463 440 857 855 849 881 902 900 860 897
30 32 32 28 36 39 40 40 47 166 165 167 171 62 79 79 76 79 83 89 85 88 80 96 82 99 126 123 134 145 137 140 190 194 202 237 271 278 240 284
– 121 153 154 151 3.4 3.8 5.2 5.7 116 118 120 122 9.9 12 12 13 13 14 15 16 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 7.2 9.2 11 13 15 17 19 21
4.7 3.4 4.8 3.2 5.8 3.6 4.9 7.9 7.3 8.9 11 9.8 11 15 12 14 13 11 14 13 12 23 22 28 19 29 33 29 34 37 49 49 61 46 53 55 70 63 70 74
119 121 153 154 151 128 130 199 200 68 67 66 65 176 188 178 175 172 169 190 186 287 286 286 286 286 285 285 285 285 285 284 618 615 612 608 605 600 594 589
169 170 172 177 183 175 180 185 192 197 200 208 213 213 201 191 195 196 204 192 191 359 346 337 337 339 339 434 455 433 452 481 431 429 443 462 506 541 562 597
-1.8 -2.9 -1.8 0.9 5.6 -4.0 -1.8 1.0 6.1 11 12 19 22 18 11 -1.8 -1.3 -5.0 -4.9 -19 -23 -48 -68 -84 -93 -97 -96 -90 -81 -80 -62 -65 -90 -100 -85 -77 -51 -23 6.4 31
12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 14 16 16 16 16 17 18 19 19 19 19 19 19 20 20 21 21 22 22

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?